Comparison of P-wave dispersion in healthy dogs, dogs with chronic valvular disease and dogs with disturbances of supraventricular conduction
© Noszczyk-Nowak et al; licensee BioMed Central Ltd. 2011
Received: 7 September 2010
Accepted: 11 March 2011
Published: 11 March 2011
P-wave dispersion (Pd) is a new ECG index used in human cardiology and veterinary medicine. It is defined as the difference between the maximum and the minimum P-wave duration recorded from multiple different ECG leads. So far no studies were performed assessing the importance of P-wave dispersion in dogs.
The current study was aimed at determining proper value of Pd in healthy dogs (group I), dogs with chronic valvular disease (group II) and dogs with disturbances of supraventricular conduction (group III). The tests were carried out in 53 healthy dogs, 23 dogs with chronic valvular disease and 12 dogs with disturbances of supraventricular conduction of various breeds, sexes and body weight from 1,5 to 80 kg, aged between 0,5 and 17 years, submitted to the ECG examination. ECG was acquired in dogs in a standing position with BTL SD-8 electrocardiographic device and analyzed once the recording was enlarged. P-wave duration was calculated in 9 ECG leads (I, II, III, aVR, aVL, aVF, V1, V2, V4) from 5 cardiac cycles.
The proper P-wave dispersion in healthy dogs was determined at up to 24 ms. P-wave dispersion was statistically significant increased (p < 0.01) in dogs with chronic valvular disease and dogs with disturbances of supraventricular conduction. In dogs with the atrial enlargement the P-wave dispersion is also higher than in healthy dogs, although no significant correlation between the size of left atria and Pd was noticed (p = 0.1, r = 0,17).
The P-wave dispersion is a constant index in healthy dogs, that is why it can be used for evaluating P wave change in dogs with chronic valvular disease and in dogs with disturbances of supraventricular conduction.
P-wave dispersion (Pd) is an ECG index evaluated in human cardiology and veterinary medicine [1–3]. The index is defined as the difference between the maximum and minimum P-wave duration recorded from different ECG leads. It is assumed that the duration of the P-wave and the Pd reflect the electrophysiological properties of the atrium muscle. As the electrical activity of the cardiac muscle displayed on the electrocardiogram is closely correlated with the conduction of specific areas of the atrium; the regional depolarization disturbances may lead to variety of the duration of the P-wave at different ECG leads. Changes in the Pd may reflect the disturbances in the inter and intra-atrial conduction and the inhomogeneous propagation of the sinus impulses. It is not clearly stated if only the conduction heterogeneity of atria (local effect) or also the various projection of the single depolarization vector at different ECG leads (projection phenomenon) [4, 5] will have the influence on the interlead variation of the P-wave duration. Important can be also the obstacle in measurements, when the P-wave amplitude is small and its onset and offset are difficult to determine.
The Pd is also evaluated in humans as a prognosis index in case of atrial fibrillation (AF) [6–8]. It is assumed, that this way, there will be a possibility to detect patients that do not show visible heart disorders although have a higher risk in developing AF [6, 7]. In veterinary medicine, up to now, the Pd has been evaluated only at healthy dogs to establish the proper values of this index . Many hopes are being placed on using Pd, as an indicator, in dogs predisposed to develop some types of supra-ventricular arrhythmia, for example AF in dogs, in dogs that are suspected to have dilated cardiomyopathy, in dogs with enlarged atria due to mitral/tricuspid insufficiency or in dogs predisposed to sinus disorders. No research have been fulfilled to evaluate the Pd in dogs with supra-ventricular conduction disorders or in dogs with enlarged atria.
The aim of this study was to evaluate the P-wave dispersion in healthy dogs, in dogs with mitral valve insufficiency and in dogs with supra-ventricular conduction disorders.
The study was performed on 88 dogs, divided into three groups. The first group included 53 dogs (22 females/31 males): 6 German Shepherds, 2 Miniature Pinschers, 3 Yorkshire Terriers, 2 Giant Schnauzers, 2 Shih-tzus, 1 Mastino Napoletano, 8 Mixed breeds, 2 Great Danes, 2 Golden Retrievers, 3 Dachshunds, 1 Irish Setter, 1 Cairn Terrier, 1 Tibetan Mastiff, 2 Rottweilers, 1 Flat Coated Retriever, 2 st. Bernards, 3 American Staffordshire Terriers, 1 Bulmastiff, 2 German Pointers, 1 West Highland White Terrier, 1 Bouvier des Flandres, 1 Beagle, 1 Border Collie, 1 Scottish Terrier, 1 Boxer, 1 Dalmatian, 1 Chinese Crested Dog. The body weights were between 1,5 and 80 kg, aged from 0.5 to 17 years. All dogs did not show abnormalities in clinical examination, ECG and echocardiography (ratio LA/Ao < 1.2)
The second group included 23 dogs with mitral valve insufficiency (5 females/18 males): 1 Shih-tzu 1 Yorkshire Terrier, 1 Miniature Pinscher, 7 Mixed breeds, 8 Dachshunds, 3 Miniature Poodles, 2 Miniature Schnauzers, body weights between 3,3 and 38 kg, aged from 8 to 17 years. All dogs in this group in clinical examination had heart murmurs (level of 3 to 5) and clinical sings of heart failure (Ib, II and IIIa, ISACHC score) , mitral valve insufficiency and the enlargement of left atria confirmed in echocardiography and ratio LA/Ao > 1.5. According to Bonagura et al the standard for LA/Ao is 1.2, although in the literature appear values up to 1.5 in healthy dogs [10–12], that is why in this study it was assumed that value LA/Ao >1.5 (group II) indicated the atria enlargement.
Tricuspid valve insufficiency of small degree was noticed at 5 dogs. Pd was calculated for dogs that were not treated earlier for cardiac disease. Group III contained 12 dogs (5 females/7 males) with supra-ventricular conduction disorders: 1 Mixed breed (sino-atrial block), 1 Great Dane (atrio-ventricular block 1'st degree), 2 Golden Retrievers (atrio-ventricular block 1'st and 2'nd degree), 2 Dachshunds (sino-atrial block, atrio-ventricular block 1'st degree), 1 Beagle (sino-atrial block), 1 Pug (atrio-ventricular block 1'st degree), 2 Miniature Schnauzers (sino-atrial block, atrio-ventricular block 1'st degree) 1 Labrador Retriever (sino-atrial block), 1 Bullmastiff (atrio-ventricular block 2'nd degree), with body weight between 7 and 70 kg and aged from 14 months till 12 years.
The animals were qualified based upon earlier investigation, preliminary clinical examination and morphological and biochemistry blood sampling (AST, ALT, urea, creatinine, Na+, K+, Ca2+, Mg2+, Cl-). No variations from normal parameters were detected. All dogs went through echocardiography to establish the size of the heart caves and functions of specific structures (contractility of the left ventricle and the function of atrio-ventricle valves). The LA/Ao ratio was obtained by measuring the left atria and aorta diameters in the ventricular's endsystolic ECG phase [11, 13]. The echocardiography examination was performed on the echocardiograph ALOKA 4000+. The probe used for echocardiography was sector type 5 MHz and 7.5 MHz.
All dogs underwent ECG in standing position on BTL SD08 equipped with net filter and different frequencies of muscular filters. The ECG signals were recorded as a direct electronic signal every 30 seconds using computer software BTL. Additionally the computer system for ECG record evaluation allows to reduce the interference of muscles on the ECG record and in the same time eliminate those artefacts. The system enables to enlarge the record 200 times while using a computer display 21,3". The electrodes are placed accordingly: right arm (red electrode), left arm (yellow electrode), right leg (black electrode) and left leg (green electrode). The precordial leads were attached as follows: V1 was placed right of sternum at the 5th intercostal space, V2 - was placed just to the left of the sternum, V4 - was placed to the left at the costochondrial junction at the 6th intercostal space . The record was analyzed carefully to calculate the P-wave dispersion. The evaluation of P-wave duration was done on 9 ECG leads (I, II, III, IV, aVR, aVL, aVF, V1, V2, V4) at five cardiac cycles. The assessment was done by the means of electronic markers on the computer screen after a 200 times enlargement of the ECG record. In every evaluated lead the duration of P-wave was measured as a distance between the onset (positive or negative deflection from the isoelectric line) and the offset (return to the isoelectric line) with precision to 1 ms. After that, minimum (Pmin) and maximum (Pmax) values of P-wave was set. The dispersion of P-wave was calculated as the difference between Pmax and Pmin and then the average from 5 measurements have been obtained.
When the electrocardiography measurements were completed all data were subjected to statistical analysis. The deviation between values of Pd were analyzed based on Mann-Whitney U test and the correlation between the objective index of atria's size (the size of the left atria compared to the size of aorta - LA/Ao) and Pd was evaluated. We carry out multiple linear regression dependence of Pd from body mass, age, sex and LA/Ao. Statistical analysis was based on program STATISTICA, version 7.1.
The studies obtained consent of the 2nd Local Ethical Commission No 06/2008.
In all evaluated groups of dogs there were more males then females.
Based upon the results from group I the mean values for Pmax, Pmin, Pd, were calculated which were accordingly: Pmax- 63.4 ± 12.7 ms, Pmin- 46.6 ± 11.5 ms, Pd- 16.8 ± 3.51 ms (range 9.2-22.6 ms, dominant = 16.2). The correct value of P-wave dispersion of healthy dogs was set as a mean value of Pd ± 2SD and it was less than 24 ms.
Pd in healthy dogs depending on the body mass
Pd in healthy dogs depending on the age
Pd in healthy dogs depending on the sex
In veterinary electrocardiography the gold standard is to perform the ECG record in a recumbence, nether less literature shows that the ECG record can be performed also in a standing or sternum position. In many publications the ECG records were compared coming from dogs that were in lateral recumbency or standing position. It has been noticed that the position of the dog does not influence the P-wave duration, P-wave amplitude or PR interval [15, 16]. Dogs standing position is used also during toxicological and pharmacological examination. In the Hanton and Rabamampiania study it is stated that the body position of the dog during recording of ECG had no major influence on most parameters. In many studies taking up the problem of the influence of the dog's position on the ECG record parameters the sufficient impact on the modified mean electrical axis is underlined, what was not evaluated in this research study [15–18]. Standing position was chosen in this study due to lack of any documented muscle interferences with duration and amplitude of P-wave and duration of PR interval, lower stress for the animal and that means less heart rhythm frequency.
The frequency and degree of degeneration of atrio-ventricular valves increases in older dogs. That is why the dogs that had the insufficiency of mitral valve were, in average, the older ones . Degeneration progress with age. In the same group of dogs the body weight was lower, which is correlated with the predisposition of smaller and miniature breeds to the degeneration of mitral valve . No dependency between the age of healthy dogs and Pd was noticed. A tendency for greater spread of Pd was observed more often in healthy dogs above 8 years old, that was pictured by the Pd standard deviation increase (table 2). There is no correlation between the body weight and Pd in healthy dogs. There is an increase of the average maximum and minimum duration of P-wave, correlated with the increase of body weight, which goes together with the increased size of the heart, particularly the size of atrias. The ratio of these values is constant, so there are no statistical differences between particular body weight groups of healthy dogs. No correlation between sex and the value of Pd was noticed, even though there were more males than females. The appearance of higher number of males is due to preferences of the owners to have male dogs, not due to the correlation between sex and heart disorders. Received values of Pd in healthy dogs, independently from age, body weight and sex had small dispersion and small standard deviation. The maximum value of Pd in this group of dogs was 20.8 ms and was lower than average Pd values in the group of dogs with mitral insufficiency (group I) and dogs with supra-ventricular conduction disorders (group III).
Presented data allow to assume that Pd value is an independent factor from body weight and sex. It is a constant parameter in healthy dogs, with no supra-ventricular conduction disturbances and changes in the atria size, resulting in low SD value in a big and diversified group of healthy dogs. This allows to use the Pd value as an independent parameter for evaluating inter and intra-atrial conduction.
There was noticed a significant increase in Pd in dogs with increased left atria due to insufficiency of the mitral valve compared to healthy dogs. Mitral valve insufficiency is a complex pathological process, in which takes part, in example, the degeneration of collagen. Acid mucopolisaccharides group around the petals of the valves which at results in nodular thickening, deformation and weakening of the petals which leads to valve insufficiency. Valve insufficiency leads to the enlargement of the belonging atria, anulus fibrosus and ventricle. In the atria appears endocardial and atria muscular fibrosis, intraparietal infarcts and changes in the arterial vessels caused by the stream of regurgitation over the insufficient valve. These processes lead to inhomogeneous propagation of the impulses in the atria which together with the enlargement of the atria impacts the increase of P-wave dispersion. It seems that Pd is more dependant from disturbances of inter and intra-ventricular conduction and inhomogeneous propagation of impulses, than from the level of left atria enlargement. Correlation wasn't noticed between Pd and the level of the enlargement of left atria. Similar results were found in humans with hypertension, who had earlier episodes of AF or at those that had attacks of AF shortly after Pd measurements. In these tests no correlation has been noticed between the value of blood pressure, size of left atria and weight of left atria [8, 19–21]. Statistically significant increase in Pd was observed in a group of dogs with supra-ventricular conduction disorders compared to healthy dogs. Average value of Pd was the highest in this group of dogs, which is directly correlated with improper atria conduction. The duration of P and Pd is dependant not only from disorders in the atrium. Anemia and activity of immune system can also lead to changes in the auriculars and speed of impulse conduction [22, 23]. Infarct, dilatated cardiomyopathy, stricture of the left atrioventricular ostium opening or congenital malformations of the heart can also lead to increased dispersion of P-valve [23–28]. In human medicine the peculiarity and sensitivity of Pd has been proved and is used as a parameter allowing to detect patients with higher risk of occurring or with the recurrence of atrial fibrillation [6–8]. Presented results, in this study, may also contribute to propagation of similar using values of P-wave dispersion for dogs, but it still demands further research. There are other factors, that can influence Pd, that should be taken under consideration when interpreting the results. Pd can increase also during endocrinology disorders such as diabetes and thyroid hyperfunction [29–32], but also at patients that have the terminal phase of renal failure [33, 34]. The changes in Pd have been noticed also in connection with changes of the tension of autonomous nervous system, for example while conducting Valsalva maneuver [35, 36] or in connection with panic attacks . That is why it is important to interpret Pd in connection with other examination results and general overview of the patient.
P-wave dispersion is a constant parameter in healthy dogs, independent from body weight, age and sex. In dogs with inter and intra-atrial conduction disturbances P-wave dispersion is significantly higher, that is why this parameter can be used to evaluate the possibility of the inter and intra-atrial conduction disturbances. In dogs with chronic valvular disease and the atrial enlargement the P-wave dispersion is also higher than in healthy dogs, although no significant correlation between the size of left atria and Pd was noticed. The dependency with association between of inter and intra-atrial conduction disturbances with Pd in this group of dogs demands further studies.
- Noszczyk-Nowak A, Pasławska U, Szałas A, Nicpoń J: P-wave dispersion in healthy dogs. A preliminary study. Bull Vet Inst Pulawy. 2008, 52: 683-688.Google Scholar
- Dilaveris PE, Gialafus JE: P wave dispersion: a novel predictor of paroxysmal AF. Ann Noninvasive Electrocardiol. 2001, 6: 159-165. 10.1111/j.1542-474X.2001.tb00101.x.View ArticlePubMedGoogle Scholar
- Villani GQ, Piepoli M, Rosi A, Capucci A: P-wave dispersion index: a marker of patients with paroxysmal atria fibrillation. Int J Cardiol. 1996, 55: 169-175. 10.1016/0167-5273(96)02677-0.View ArticlePubMedGoogle Scholar
- Spach MS, Miller WT, Geselowitz DB, Barr RC, Kootsey JM, Johnson EA: The discontinuous nature of propagation in normal canine cardiac muscle: evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ Res. 1981, 38: 39-54.View ArticleGoogle Scholar
- Ndrepepea G, Zrenner B, Deisenhfer I, Karch M, Schneider M, Schreieck J, Schmitt C: Relationship between surface electrocardiogram characteristics and endocardial activation sequence in patients with typical atrial flutter. Z Kardiol. 2000, 89: 527-537. 10.1007/s003920070225.View ArticleGoogle Scholar
- Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998, 135: 733-738. 10.1016/S0002-8703(98)70030-4.View ArticlePubMedGoogle Scholar
- Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, Oto A, Ozmen F, Kes S: P wave dispersion on 12 lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000, 23: 1109-1112. 10.1111/j.1540-8159.2000.tb00910.x.View ArticlePubMedGoogle Scholar
- Dilaveris PE, Gialafos EJ, Chrissos D, Andrikopoulos GK, Richter DJ, Lazaki E, Gialafos JE: Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens. 1999, 17: 1463-1470. 10.1097/00004872-199917100-00015.View ArticlePubMedGoogle Scholar
- Freeman LM, Rush JE, Farabaugh AE, Must A: Development and evaluation of a questionnaire for assessing health-related quality of life in dogs with cardiac disease. J Am Vet Med Assoc. 2005, 226: 1864-1868. 10.2460/javma.2005.226.1864.View ArticlePubMedGoogle Scholar
- Koie H, Kanayama K, Sakai T, Takeuschi A: Evaluation of diagnostics availability of continuous ANP assai and LA/AO ratio in left heart insufficient dogs. J Vet Med Sci. 2001, 63: 1237-1240. 10.1292/jvms.63.1237.View ArticlePubMedGoogle Scholar
- Bonagura JD, O'Grady MR, Herring DS: Echocardiography. Principles of interpretation. Vet Clin North Am Small Anim Pract. 1985, 15: 1177-1194.View ArticlePubMedGoogle Scholar
- Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, Arisawa K, Kurita T, Nunokawa K, Hirakawa A, Tanaka S, Hirose H: Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency. J Vet Med Sci. 2009, 71: 925-929. 10.1292/jvms.71.925.View ArticlePubMedGoogle Scholar
- Allen DG: Echocardiography as a research and clinical tool in veterinary medicine. Can Vet J. 1982, 23: 313-316.PubMed CentralPubMedGoogle Scholar
- Kraus MS, Moise NS, Rashniw M, Dykes N, Erb HN: Morphology of ventricular arrhythmias in the boxer as measured by 12-lead electrocardiography with pace-mapping comparison. J Vet Intern Med. 2002, 16: 153-158. 10.1111/j.1939-1676.2002.tb02347.x.View ArticlePubMedGoogle Scholar
- Coleman MG, Robson MC: Evaluation of six-lead electrocardiograms obtained from dogs in a sitting position or sterna recumbency. Am J Vet Res. 2005, 66: 233-237. 10.2460/ajvr.2005.66.233.View ArticlePubMedGoogle Scholar
- Rashniw M, Porciello F, Erb HN, Fruganti : Effect of body position on the 6-lead ECG of dogs. J Vet Intern Med. 2002, 16: 69-73. 10.1111/j.1939-1676.2002.tb01608.x.View ArticleGoogle Scholar
- Hanton G, Rabemampianina Y: The electrocardiogram of the Beagle dog: reference values and effect of sex, genetic strain, body position and heart rate. Lab Anim. 2006, 60: 123-136. 10.1258/002367706776319088.View ArticleGoogle Scholar
- Pasławska U, Kurski B, Noszczyk-Nowak A, Grudziński P, Nicpoń J, Kungl K: Analysis of mean electric al axis and amplitude of R wave in relation to particular disorders and body position during ECG examinations [nn Polish]. Medycyna Wet. 2005, 61: 1015-1017.Google Scholar
- Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R, Keene R, Luis-Fuentes V, Stepien R: Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009, 23: 1142-1150. 10.1111/j.1939-1676.2009.0392.x.View ArticlePubMedGoogle Scholar
- Ciaroni S, Cuenoud L, Bloch A: Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J. 2000, 139: 814-819. 10.1016/S0002-8703(00)90012-7.View ArticlePubMedGoogle Scholar
- Ozer N, Aytemir K, Atalar E, Sade E, Aksöyek S, Ovünç K, Açýl T, Nazlý N, Ozmen F, Oto A, Kes S: P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000, 23: 1859-1862.View ArticlePubMedGoogle Scholar
- Dilaveris PE, Andrikopoulos GK, Metaxas G, Richter DJ, Avgeropoulou CK, Androulakis AM, Gialafos EJ, Michaelides AP, Toutouzas PK, Gialafos JE: Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous angina episodes. Pacing Clin Electrophysiol. 1999, 22: 1640-1647. 10.1111/j.1540-8159.1999.tb00384.x.View ArticlePubMedGoogle Scholar
- Baykan M, Celik S, Erdol C, Durmuç I, Orem C, Küçükosmanoğlu M, Yilmaz R: Effects of P wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction. Ann Noninvasive Electrocardiol. 2003, 8: 18-21. 10.1046/j.1542-474X.2003.08104.x.View ArticleGoogle Scholar
- Jolda-Mydlowska B, Kobusiak-Prokopowicz M: Estimation of the P wave and PQ interval dispersion in patients with the recent myocardial infarction. Pol Merkuriusz Lek. 2005, 18: 499-502.Google Scholar
- Ozer N, Yavuz B, Can I, Atalar E, Aksöyek S, Ovünç K, Ozmen F, Kes S: Doppler tissue evaluation of intra-atrial and interatrial electromechanical delay and comparsion with P-wave dispersion in patients with mitral stenosis. J Am Soc Echocardiogr. 2005, 18: 945-948. 10.1016/j.echo.2005.01.015.View ArticlePubMedGoogle Scholar
- Ho TF, Chia EL, Yip WC, Chan KY: Analysis of P-wave and P dispersion in children with secundum atrial septal defect. Ann Noninvasive Electrocardiol. 2001, 6: 305-309. 10.1111/j.1542-474X.2001.tb00123.x.View ArticlePubMedGoogle Scholar
- Hallioglu O, Aytemir K, Celiker A: The significance of P wave duration and P wave dispersion for risk assessment of atrial tachyarrhytmias In patients with corrected tetralogy of Fallot. Ann Noninvasive Electrocardiol. 2004, 9: 339-344. 10.1111/j.1542-474X.2004.94569.x.View ArticlePubMedGoogle Scholar
- Senen K, Turhan H, Riza Erbay A, Basar N, Saatci Yasar A, Sahin O, Yetkin E: P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail. 2004, 6: 567-956.View ArticlePubMedGoogle Scholar
- Guntekin U, Gunes Y, Simsek H, Tuncer M, Arslan S: P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment. Indian Pacing Electrophysiol J. 2009, 9: 251-259.PubMed CentralPubMedGoogle Scholar
- Cetinarslan B, Akkoyun M, Cantürk Z, Tarkun I, Kahranman G, Komsuoglu B: Duration of the P wave and P wave dispersion in subclinical hyperthyroidism. Endocr Pract. 2003, 9: 200-203.View ArticlePubMedGoogle Scholar
- Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E, Demir AD, Soylu MO, Erdogan MF, Kisacik HL, Korkmaz S: Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol. 2005, 99: 59-64. 10.1016/j.ijcard.2003.11.040.View ArticlePubMedGoogle Scholar
- Yazici M, Ozdemir K, Altunkeser BB, Kayrak M, Duzenli MA, Vatankulu MA, Soylu A, Ulgen MS: The Effect of diabetes mellitus on the P-wave dispersion. Circ J. 2007, 71: 880-883. 10.1253/circj.71.880.View ArticlePubMedGoogle Scholar
- Szabo Z, Kakuk G, Fülöp T, Mátyus J, Balla J, Kárpáti I, Juhász A, Kun C, Karányi Z, Lorincz I: Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant. 2002, 17: 1634-1638. 10.1093/ndt/17.9.1634.View ArticlePubMedGoogle Scholar
- Tezcan UK, Amasyali B, Can I, Aytemir K, Köse S, Yavuz I, Kursaklioglu H, Içik E, Demirtaç E, Oto A: Increased P wave dispersion and maximum P wave duration after hemodialysis. Ann Noninvasive Electrocardiol. 2004, 9: 34-38. 10.1111/j.1542-474X.2004.91529.x.View ArticlePubMedGoogle Scholar
- Tükek T, Akkaya V, Demirel S, Sözen AB, Kudat H, Atilgan D, Ozcan M, Güven O, Korkut F: Effect of Valsalva maneuver on surface electrocardiografic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol. 2000, 85: 896-899.View ArticlePubMedGoogle Scholar
- Altunkeser BB, Ozdemir K, Gok H: The effect of Valsalva maneuver on P wave in 12-lead surface electrocardiology in patients with paroxysmal atrial fibrillation. Angiology. 2002, 53: 443-449. 10.1177/000331970205300411.View ArticlePubMedGoogle Scholar
- Yavuzkir M, Atmaca M, Dagli N, Balin M, Karaca I, Mermi O, Tezcan E, Aslan IN: P-wave dispersion in panic disorder. Psychosom Med. 2007, 69: 344-347. 10.1097/PSY.0b013e3180616900.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.